This article has Open Peer Review reports available.
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study
© The Author(s). 2017
Received: 2 April 2017
Accepted: 24 November 2017
Published: 4 December 2017
Open Peer Review reports
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|2 Apr 2017||Submitted||Original manuscript|
|8 Aug 2017||Reviewed||Reviewer Report - Katherine Tkaczuk|
|16 Aug 2017||Reviewed||Reviewer Report - Ioannis Voutsadakis|
|5 Sep 2017||Reviewed||Reviewer Report - Bora Lim|
|8 Oct 2017||Author responded||Author comments - Sakura Iizumi|
|Resubmission - Version 2|
|8 Oct 2017||Submitted||Manuscript version 2|
|27 Oct 2017||Reviewed||Reviewer Report - Bora Lim|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|24 Nov 2017||Editorially accepted|
|4 Dec 2017||Article published||10.1186/s12885-017-3846-8|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.